Medicure Inc. (OTCMKTS:MCUJF – Get Rating) was the target of a large decline in short interest in the month of August. As of August 15th, there was short interest totalling 100 shares, a decline of 66.7% from the July 31st total of 300 shares. Based on an average trading volume of 16,600 shares, the days-to-cover ratio is presently 0.0 days.
Medicure Trading Down 6.2 %
Shares of MCUJF stock opened at $0.79 on Friday. The company's fifty day simple moving average is $0.84 and its two-hundred day simple moving average is $0.84. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.61 and a quick ratio of 1.18. Medicure has a 1 year low of $0.64 and a 1 year high of $1.10. The stock has a market capitalization of $8.10 million, a price-to-earnings ratio of 14.04 and a beta of 0.83.
Get Medicure alerts:Medicure (OTCMKTS:MCUJF – Get Rating) last issued its earnings results on Monday, May 30th. The company reported $0.04 earnings per share (EPS) for the quarter. Medicure had a net margin of 3.40% and a return on equity of 4.28%. The business had revenue of $4.51 million for the quarter.
About Medicure
(Get Rating)Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Articles
- Get a free copy of the StockNews.com research report on Medicure (MCUJF)
- Should AbbVie Inc. Have a Place in Your Dividend Portfolio?
- Is PayPal A Buy After Post-Earnings Price Jump?
- Williams-Sonoma's High-End Consumers Are Still Spending
- Snowflake Stock Soars On Strong Results
- ShockWave Stuns With 40% Post-Earnings Price Move: Is It A Buy?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.